Aude Chapuis

Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to deal with strong tumors

From left: Affini-T scientific co-founders and Fred Hutch investigators Philip Greenberg, Aude Chapuis, and Thomas Schmitt. (Fred Hutch Photos) New…